Abortion Rate

States with abortion restrictions had a greater number of internet searches containing keywords related to self-managed abortions compared with states without restrictions, according to a research letter published in JAMA Surgery.

A bill introduced to the Senate will provide funding for the next 5 years to medical school programs for abortion care training and for students who have to travel out of state for abortion training, according to a press release.

Panelists at the ACOG Annual Clinical & Scientific Meeting discussed the safety, efficacy and increasing interest in self-managed abortions in the wake of the Dobbs decision.

The ability of Texas health care professionals to provide evidence-based abortion care to women with medically complex pregnancies was disrupted after Texas Senate Bill 8 was implemented, researchers reported in Obstetrics & Gynecology.

BALTIMORE — A special late-breaking session at the ACOG Annual Scientific & Clinical meeting featured the most up-to-date information and guidance on availability of the abortion drug mifepristone.

BALTIMORE — A one-time dose of off-label cabergoline after second-trimester abortion or pregnancy loss was effective for preventing symptomatic breast engorgement, according to data presented at the ACOG Annual Clinical & Scientific Meeting.

BALTIMORE — A new study found that the Dobbs decision and subsequent restrictive abortion laws are impacting residency application decisions for medical students across all specialties.

BALTIMORE — Instagram is being used to distribute accurate and inaccurate medical information about abortion by both medical and nonmedical professionals, researchers reported at the ACOG Annual Clinical & Scientific Meeting.

Since the Dobbs decision in June 2022 that overturned the federal right to abortion, access to abortion and abortifacient drugs has been a source of debate for physicians and legislators.

Both abortion- and contraception-related internet searches increased from the weeks before and the weeks after the Supreme Court Dobbs decision in June 2022, according to a retrospective cross-sectional study published in JAMA Health Forum.